<DOC>
	<DOCNO>NCT00983749</DOCNO>
	<brief_summary>The purpose study determine external counterpulsation ( ECP ) feasible perform , tolerable , safe treatment patient acute ischemic stroke ( i.e. , blockage one artery supply part brain ) , assess type effect might 1 ) velocity blood flow artery supply brain 2 ) stroke symptom . The hypothesis study ECP feasible safe perform , tolerable patient acute ischemic stroke pressure increase velocity arterial blood flow brain .</brief_summary>
	<brief_title>Safety Study External Counterpulsation Treatment Acute Ischemic Stroke</brief_title>
	<detailed_description>A stroke usually cause blockage one arteries carry blood brain . Sometimes stroke , may small amount blood flow manage get around blockage , may possible amount damage stroke may reduce increase blood flow . External counterpulsation ( ECP ) procedure machine use electrical signal heart detectable surface body order time inflation cuff ( similar blood pressure cuff ) wrap around patient 's leg ( calf , thigh buttock ) . Using read electrical activity patient 's heart ( electrocardiogram , ECG , monitor ) , machine inflates cuff air right time heart beat , diastole , order change blood pressure way show increase blood flow kidney , skin , eye , heart , brain . In study , patient present within first 48 hour acute ischemic stroke ( i.e. , blockage one artery supply part brain ) randomly assign either ( 1 ) 1-hour treatment external counterpulsation ( ECP ) apply pressure typically therapeutic , ( 2 ) 1-hour treatment ECP minimal pressure control group . ECP-induced change brain artery flow velocity assess ultrasound prior ECP group , optimal pressure result augmentation flow velocity determine . A neurological exam perform prior , , ECP group , order ass change stroke symptom related ECP . Patients follow 30 day . The main goal trial evaluate ECP safe feasible use treatment stroke . In addition , trial enable assessment whether ECP increase blood flow brain affect neurological symptom patient stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Adults age 18 85 , inclusive Symptoms consistent acute ischemic stroke , measurable neurological deficit presentation Ability initiate external counterpulsation within 48 hour stroke onset No evidence hemorrhage CT scan MRI MCA distribution stroke : total partial anterior circulation infarct ( TACI PACI Oxfordshire criterion ) consistent MCA distribution ischemia , lacunar stroke felt investigator possibly involve deep perforating branch MCA territory ( LACI Oxfordshire criterion ) Rapidly resolve stroke symptom consistent transient ischemic attack Severe stroke define NIHSS &gt; 22 Intracranial hemorrhage ( SAH , EDH , SDH , IPH , hemorrhagic conversion ) CT scan Brain tumor brain abscess CT scan MRI Presentation consistent subarachnoid hemorrhage ( sudden , severe thunderclap headache , associate third nerve palsy ) History cerebral aneurysm , AVM , hemorrhagic stroke Either treatment plan treatment current stroke standard thrombolytic therapy ( intravenous intraarterial ) neurothrombectomy History low limb amputation ankle History untreated aortic dissection History suspicion thoracic abdominal aortic aneurysm Known significant anomaly heart , aorta , great vessel would complicate elevated diastolic pressure . BP &gt; 180/100 remains minimal treatment ( one two dos antihypertensive agent , determine investigator ) History nontrivial aortic regurgitation , symptomatic valvular heart disease determine investigator risk worsen ECP Significant symptomatic congestive heart failure ( orthopnea , CHFrelated dyspnea , rales jugular venous distention exam ) leave ventricular ejection fraction know &lt; 30 % Diagnosis significant low extremity peripheral vascular occlusive disease ( PVOD ) , symptomatic PVOD determine investigator ( especially symptoms claudication ) Phlebitis , stasis ulcer , severe varicosity Diagnosis DVT within past month , current symptom strongly suggestive new DVT , asymmetric calf leg swelling , discomfort , erythema ( evaluated screening duplex ) Pacemaker automate implanted defibrillator ( AICD ) A cardiac dysrhythmia ( atrial fibrillation atrial flutter , frequent premature ventricular contraction ( PVCs ) premature atrial contraction ( PACs ) determine investigator ) would interfere ECP trigger Pregnancy ( determine urine pregnancy test female childbearing age ) Known coagulopathy , thrombocytopenia platelet count &lt; 100,000 , take warfarin INR &gt; 2.0 . History positive chronic low back pain , radiculopathy suggestive herniated lumbar disc , related surgery Known collagen vascular disease Obesity degree ( determined investigator ) would prevent proper placement and/or activation counterpulsation cuff Any psychological , social , legal condition would interfere ability patient surrogate give Informed Consent and/or capacity comply study requirement , include necessary time commitment An inadequate temporal window TCD insonation . Currently involve involve clinical trial within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>External Counterpulsation</keyword>
	<keyword>Counterpulsation , Diastolic</keyword>
	<keyword>Ultrasonography , Doppler , Transcranial</keyword>
	<keyword>Blood Flow Velocity</keyword>
	<keyword>Neurologic Deficit</keyword>
</DOC>